ADENOSINE is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Wockhardt Limited. The primary component is Adenosine.
| Product ID | 55648-630_2003e556-60bd-4127-ab47-324acb610460 |
| NDC | 55648-630 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ADENOSINE |
| Generic Name | Adenosine |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2013-03-30 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA079147 |
| Labeler Name | Wockhardt Limited |
| Substance Name | ADENOSINE |
| Active Ingredient Strength | 3 mg/mL |
| Pharm Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2013-03-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA079147 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-03-30 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA090220 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-07-20 |
| Marketing Category | ANDA |
| Application Number | ANDA090220 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-07-20 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA079147 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-03-30 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA079147 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-03-30 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA079147 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-03-30 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA090220 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-07-20 |
| Marketing Category | ANDA |
| Application Number | ANDA090220 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-07-20 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| ADENOSINE | 3 mg/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0404-9809 | Adenosine | Adenosine |
| 0409-1932 | Adenosine | ADENOSINE |
| 0641-6113 | Adenosine | Adenosine |
| 0703-8776 | Adenosine | Adenosine |
| 0703-8777 | Adenosine | Adenosine |
| 10019-063 | Adenosine | ADENOSINE |
| 16714-180 | Adenosine | Adenosine |
| 16714-556 | Adenosine | Adenosine |
| 16714-972 | Adenosine | Adenosine |
| 16714-997 | Adenosine | Adenosine |
| 17478-542 | Adenosine | Adenosine |
| 17478-544 | Adenosine | Adenosine |
| 17478-953 | Adenosine | Adenosine |
| 23155-258 | Adenosine | Adenosine |
| 23155-259 | Adenosine | Adenosine |
| 25021-301 | adenosine | adenosine |
| 68083-101 | Adenosine | Adenosine |
| 68083-157 | Adenosine | Adenosine |
| 68083-156 | Adenosine | Adenosine |
| 70518-1232 | Adenosine | Adenosine |
| 71872-7035 | Adenosine | Adenosine |
| 50090-1548 | Adenosine | Adenosine |
| 51662-1345 | ADENOSINE | ADENOSINE |
| 52584-026 | Adenosine | Adenosine |
| 55150-192 | Adenosine | Adenosine |
| 55150-193 | Adenosine | Adenosine |
| 55154-1279 | Adenosine | Adenosine |
| 55648-630 | ADENOSINE | ADENOSINE |
| 63323-651 | Adenosine | Adenosine |
| 64679-630 | ADENOSINE | ADENOSINE |
| 67457-856 | Adenosine | Adenosine |
| 67457-854 | adenosine | adenosine |
| 67457-855 | adenosine | adenosine |
| 67457-857 | Adenosine | Adenosine |
| 71872-7099 | Adenosine | Adenosine |
| 67457-859 | Adenosine | Adenosine |
| 67457-858 | Adenosine | Adenosine |
| 51662-1450 | ADENOSINE | ADENOSINE |
| 0469-8234 | Adenocard | adenosine |
| 42491-1200 | Tissen ICM 10 | Adenosine |
| 42491-1100 | Tissen NF 10 | Adenosine |